FIELD: medicine, biochemistry. SUBSTANCE: invention relates to application of inhibitors of tyrosinase as an agent that prevents producing melanin by iris melanocytes caused by derivatives of α- and PGF2α Invention relates to pharmaceutical preparations containing derivative of PGF2 as agent against glaucoma and tyrosinase inhibitor. Invention relates to method for prevention of producing melanin by iris melanocytes involving administration of effective amount of tyrosinase inhibitor. Invention provides the realization of indicated designation. EFFECT: valuable properties of tyrosinase inhibitor. 11 cl, 2 tbl
Authors
Dates
2003-12-10—Published
1998-04-21—Filed